Editas Medicine, Inc. — Director's Dealing 2016

Feb 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2016-02-03

Reporting Person: MENDLEIN JOHN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-03	Stock Option (right to buy)	$16	A	96153	Acquired	2026-02-02	Common Stock (96153)	Direct

Footnotes

F1: This option was granted on February 3, 2016 and is scheduled to vest over three years in equal monthly installments of 1/36th of the shares beginning on February 24, 2016 through January 24, 2019.